Successful Completion of Second Renal Denervation (RDN) Therapy
We are proud to share another remarkable achievement in advanced cardiovascular care with the successful completion of our second Renal Denervation (RDN) therapy case. This milestone reflects our commitment to offering cutting-edge treatment options for patients battling conditions that are difficult to manage through conventional methods.
Renal Denervation (RDN) is an innovative, minimally invasive procedure designed for patients with resistant hypertension—a condition where blood pressure remains high despite the use of multiple medications. The procedure works by selectively disrupting the overactive sympathetic nerves surrounding the renal arteries. These nerves play a key role in blood pressure regulation, and by reducing their activity, RDN helps achieve better and sustained blood pressure control.
Seeking Care? We are here to help!
Contact Details
The success of this procedure marks significant progress in the management of resistant hypertension, especially for patients who have not responded adequately to traditional therapies. It opens the door to improved long-term outcomes, reduced cardiovascular risks, and enhanced quality of life for individuals living with chronic, uncontrolled blood pressure.
This achievement was made possible under the expertise of Dr. Harshal Ingle and Dr. C.N. Makhale, distinguished Interventional Cardiologists at Ruby Hall Clinic, Pune. Their proficiency in advanced cardiac and vascular interventions ensures that patients have access to world-class treatments backed by proven clinical excellence.
This successful RDN therapy case reaffirms our dedication to bringing advanced cardiac solutions to those who need them the most—offering renewed hope, measurable improvement, and a healthier future.
